These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12579768

  • 1. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
    Fan TY, Wei SL, Yan WW, Ding WX.
    Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
    [Abstract] [Full Text] [Related]

  • 2. An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets.
    Fan TY, Wei SL, Yan WW, Chen DB, Li J.
    J Control Release; 2001 Dec 13; 77(3):245-51. PubMed ID: 11733092
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O, Kanerva H, Vidgren M, Urtti A, Ketolainen J.
    J Control Release; 2004 Mar 24; 95(3):515-20. PubMed ID: 15023462
    [Abstract] [Full Text] [Related]

  • 4. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman, K H Y, Jia Woei W.
    Pak J Pharm Sci; 2005 Apr 24; 18(2):44-8. PubMed ID: 16431398
    [Abstract] [Full Text] [Related]

  • 5. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD, Liu Y, Tang X, Zhang Q.
    Eur J Pharm Biopharm; 2006 Oct 24; 64(2):185-92. PubMed ID: 16797948
    [Abstract] [Full Text] [Related]

  • 6. Study of the release mechanism of diltiazem hydrochloride from matrices based on chitosan-alginate and chitosan-carrageenan mixtures.
    Tapia C, Corbalán V, Costa E, Gai MN, Yazdani-Pedram M.
    Biomacromolecules; 2005 Oct 24; 6(5):2389-95. PubMed ID: 16153073
    [Abstract] [Full Text] [Related]

  • 7. [Preparation of nifidipine pulsatile release tablets].
    Zhang Y, Zhang ZR.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar 24; 35(2):261-3. PubMed ID: 15071935
    [Abstract] [Full Text] [Related]

  • 8. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D, Zheng W, Coots LB, McGinity JW.
    Eur J Pharm Biopharm; 2007 Sep 24; 67(2):464-75. PubMed ID: 17451929
    [Abstract] [Full Text] [Related]

  • 9. [Preparation and in vitro release characteristics of pulsed-release tablets of Apocynum venetum].
    Yang H, Xie F, Yang Y, Luo Y.
    Zhongguo Zhong Yao Za Zhi; 2011 Jun 24; 36(11):1427-30. PubMed ID: 22779170
    [Abstract] [Full Text] [Related]

  • 10. Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurbiprofen.
    Veerareddy PR, Vemula SK.
    J Drug Target; 2012 Sep 24; 20(8):703-14. PubMed ID: 22845842
    [Abstract] [Full Text] [Related]

  • 11. Comparative bioavailability of two tablet preparations of diltiazem in healthy volunteers.
    De Bernardis E, Candido P, Lorefice R, Picari M, Rizza V.
    Arzneimittelforschung; 1992 Jan 24; 42(1):25-7. PubMed ID: 1586376
    [Abstract] [Full Text] [Related]

  • 12. Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability.
    El-Kamel AH, Al-Gohary OM, Hosny EA.
    J Microencapsul; 2003 Jan 24; 20(2):211-25. PubMed ID: 12554376
    [Abstract] [Full Text] [Related]

  • 13. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
    Xu X, Sun M, Zhi F, Hu Y.
    Int J Pharm; 2006 Mar 09; 310(1-2):139-45. PubMed ID: 16413710
    [Abstract] [Full Text] [Related]

  • 14. Development and pharmacokinetics of a new sustained-release formulation of diltiazem.
    Thiercelin JF, Necciari J, Caplain H, Cournot A, Combes M, Desmolin H, Flouvat B.
    J Cardiovasc Pharmacol; 1990 Mar 09; 16 Suppl 1():S31-7. PubMed ID: 1706011
    [Abstract] [Full Text] [Related]

  • 15. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA, el-Helw AR, al-Mesned AF, Bayomi MA, el-Gorashi AS.
    Boll Chim Farm; 2003 Mar 09; 142(1):14-20. PubMed ID: 12680034
    [Abstract] [Full Text] [Related]

  • 16. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
    Bendas ER.
    Arch Pharm Res; 2009 Sep 09; 32(9):1317-29. PubMed ID: 19784589
    [Abstract] [Full Text] [Related]

  • 17. Effect of concomitant colestipol hydrochloride administration on the bioavailability of diltiazem from immediate- and sustained-release formulations.
    Turner SW, Jungbluth GL, Knuth DW.
    Biopharm Drug Dispos; 2002 Dec 09; 23(9):369-77. PubMed ID: 12469330
    [Abstract] [Full Text] [Related]

  • 18. Comparison of bioavailability and pharmacodynamics of diltiazem from two pharmaceutical preparations.
    Dange SV, Nandal DH, Gokhale VS, Shah KU, Kadam DB.
    Indian J Physiol Pharmacol; 1992 Jul 09; 36(3):205-8. PubMed ID: 1473854
    [Abstract] [Full Text] [Related]

  • 19. Comparison of diltiazem bioavailability from 3 marketed extended-release products for once-daily administration: implications of chronopharmacokinetics and dynamics.
    Eradiri O, Midha KK.
    Int J Clin Pharmacol Ther; 1997 Sep 09; 35(9):369-73. PubMed ID: 9314089
    [Abstract] [Full Text] [Related]

  • 20. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM, Ren Q, Zhang WZ, Shen HF, Rong ZX, Fang C, Chen HZ.
    J Pharm Pharmacol; 2008 Jul 09; 60(7):817-22. PubMed ID: 18549667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.